ITC Institutes Investigation (337-TA-1316) In Certain Pneumatic Compression Devices

OM
Oblon, McClelland, Maier & Neustadt, L.L.P

Contributor

Oblon is among the largest US law firms that exclusively practice IP law. Businesses worldwide depend on Oblon to establish, protect and leverage their IP assets. Our team of 100+ legal professionals includes some of the country’s most respected practitioners. Most attorneys hold advanced degrees in engineering, physics, chemistry, biotechnology and other scientific disciplines. Oblon is headquartered within steps of the USPTO office in Alexandria, Virginia. 
On May 31, 2022, the ITC issued a Notice of Investigation in Certain Pneumatic Compression Devices and Components Thereof (Inv. No. 337-TA-1316).
United States Intellectual Property

On May 31, 2022, the ITC issued a Notice of Investigation in Certain Pneumatic Compression Devices and Components Thereof (Inv. No. 337-TA-1316).

By way of background, this investigation is based on an April 29, 2022 complaint filed by Precision Holdings USA Inc. of Rocklin, California and Innovamed Health LLC of San Antonio, Texas alleging violations of Section 337 by Respondents ManaMed Inc. of Las Vegas, Nevada; Grandway Healthcare Limited of Hong Kong; Vive Health LLC d/b/a Coretech of Naples, Florida; and Medline Industries Inc. of Northfield, Illinois in the unlawful importation/sale of certain pneumatic compression devices and components thereof that infringe U.S. Patent Nos. 10,058,475 and 10,912,704. See our May 2, 2022 post for more details regarding the complaint.

According to the Notice, the Office of Unfair Import Investigations will participate as a party in the investigation. Further, Chief ALJ Clark S. Cheney issued a notice indicating that ALJ Bryan F. Moore will preside in the investigation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More